Goodrx Holdings Inc
NASDAQ:GDRX
Relative Value
The Relative Value of one GDRX stock under the Base Case scenario is 10.57 USD. Compared to the current market price of 7.2 USD, Goodrx Holdings Inc is Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
GDRX Competitors Multiples
Goodrx Holdings Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -320 | 33.2 | -108.5 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
37.8B USD | 16 | 71.9 | 73.1 | 78.6 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
JP |
M3 Inc
TSE:2413
|
1.5T JPY | 6.3 | 31.8 | 17.2 | 19.4 | ||
MY |
U
|
Ucrest Bhd
KLSE:UCREST
|
45.4B MYR | 2 625.6 | 7 127.4 | 4 917.9 | 7 075 | |
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
10.8B AUD | 74.1 | 155.5 | 106.8 | 106.8 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
6.4B USD | 10.3 | -303.3 | -159.1 | -147.9 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.1B USD | 10.8 | 36.7 | 25.1 | 26.7 | ||
SE |
Sectra AB
STO:SECT B
|
39.8B SEK | 24.3 | 93.7 | -61.6 | -61.6 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.7B USD | 1.9 | -26.2 | 30.3 | 322.9 |